Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Aveanna Healthcare Holdings Inc is a medical care facilities business based in the US. Aveanna Healthcare shares (AVAH) are listed on the NASDAQ and all prices are listed in US Dollars. Aveanna Healthcare employs 42,000 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$6.72|
|52-week range||$7.16 - $13.00|
|50-day moving average||$8.57|
|200-day moving average||$10.43|
|Wall St. target price||$15.10|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.66|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||-7.57%|
|1 month (2021-09-16)||-23.02%|
|3 months (2021-07-16)||-38.74%|
|6 months (2021-04-12)||N/A|
|1 year (2020-10-12)||N/A|
|2 years (2019-10-12)||N/A|
|3 years (2018-10-12)||N/A|
|5 years (2016-10-12)||N/A|
Valuing Aveanna Healthcare stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Aveanna Healthcare's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Aveanna Healthcare's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $130.2 million.
The EBITDA is a measure of a Aveanna Healthcare's overall financial performance and is widely used to measure a its profitability.
To put Aveanna Healthcare's EBITDA into context you can compare it against that of similar companies.
|Revenue TTM||$1.6 billion|
|Operating margin TTM||6.88%|
|Gross profit TTM||$454.5 million|
|Return on assets TTM||3.34%|
|Return on equity TTM||-21.2%|
|Market capitalisation||$1.3 billion|
TTM: trailing 12 months
There are currently 1.4 million Aveanna Healthcare shares held short by investors – that's known as Aveanna Healthcare's "short interest". This figure is 6.4% down from 1.5 million last month.
There are a few different ways that this level of interest in shorting Aveanna Healthcare shares can be evaluated.
Aveanna Healthcare's "short interest ratio" (SIR) is the quantity of Aveanna Healthcare shares currently shorted divided by the average quantity of Aveanna Healthcare shares traded daily (recently around 282208.98203593). Aveanna Healthcare's SIR currently stands at 5.01. In other words for every 100,000 Aveanna Healthcare shares traded daily on the market, roughly 5010 shares are currently held short.
To gain some more context, you can compare Aveanna Healthcare's short interest ratio against those of similar companies.
However Aveanna Healthcare's short interest can also be evaluated against the total number of Aveanna Healthcare shares, or, against the total number of tradable Aveanna Healthcare shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aveanna Healthcare's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Aveanna Healthcare shares in existence, roughly 10 shares are currently held short) or 0.0328% of the tradable shares (for every 100,000 tradable Aveanna Healthcare shares, roughly 33 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Aveanna Healthcare.
Find out more about how you can short Aveanna Healthcare stock.
We're not expecting Aveanna Healthcare to pay a dividend over the next 12 months.
You may also wish to consider:
Aveanna Healthcare Holdings Inc. , a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children; nursing services in school settings in which our caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; unskilled nursing services; and employer of record support services, as well as in-clinic and home-based pediatric therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers a line of durable medical equipment and enteral nutrition supplies to adults and children delivered on a periodic or as-needed basis.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.